{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,16]],"date-time":"2025-11-16T07:48:49Z","timestamp":1763279329968,"version":"build-2065373602"},"reference-count":35,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T00:00:00Z","timestamp":1645056000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"King Abdullah II Fund for Development","award":["2020\/4"],"award-info":[{"award-number":["2020\/4"]}]},{"name":"Deanship of Scientific Research, The University of Jordan","award":["19\/2019\/1162","19\/2019\/1164"],"award-info":[{"award-number":["19\/2019\/1162","19\/2019\/1164"]}]},{"name":"King Hussein Cancer Center","award":["19KHCC109"],"award-info":[{"award-number":["19KHCC109"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brain Sciences"],"abstract":"<jats:p>p27 and p57 are tumor suppressors that are dysregulated in many cancers. We investigated the immunohistochemical expression of p27 and p57 in ependymoma, with a secondary emphasis on cyclin D1, nestin, and Ki-67. Sixty-five patients diagnosed with ependymoma were included. Clinical and tumoral data were retrieved, and the expression of p27, p57, cyclin D1, nestin, and Ki-67 was measured. Pearson\u2019s \u03c72 test was used to measure associations and the Kaplan\u2013Meier method was used for survival analysis. p27 underexpression was significantly associated with pseudopalisading necrosis in tumors with foci of necrosis (p = 0.004). Cyclin D1 overexpression was associated with intracranial (p = 0.044), recurrent (p = 0.022) and grade 3 tumors (p = 0.016); nestin overexpression was associated with supratentorial (p = 0.025), mitotically active (p &lt; 0.001), and grade 3 tumors (p = 0.004); Ki-67 overexpression was associated with supratentorial (p = 0.044) and grade 3 tumors (p &lt; 0.001) and the 3 main features of anaplasia. None of the markers were intercorrelated or predictive of overall survival. In conclusion, p27 underexpression in tumors with foci of necrosis signals a pseudopalisading pattern. Cyclin D1, nestin, and Ki-67 are useful markers in ependymoma, but evidence-based cutoff values are required to standardize this interpretation.<\/jats:p>","DOI":"10.3390\/brainsci12020282","type":"journal-article","created":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T20:24:26Z","timestamp":1645129466000},"page":"282","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Immunohistochemical Expression of p27Kip1, p57Kip2, Cyclin D1, Nestin, and Ki-67 in Ependymoma"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0826-4954","authenticated-orcid":false,"given":"Shahad","family":"Iqneibi","sequence":"first","affiliation":[{"name":"School of Medicine, The University of Jordan, Amman 11942, Jordan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamil","family":"Nazzal","sequence":"additional","affiliation":[{"name":"School of Medicine, The University of Jordan, Amman 11942, Jordan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Basma","family":"Owda","sequence":"additional","affiliation":[{"name":"School of Medicine, The University of Jordan, Amman 11942, Jordan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hala","family":"Sultan","sequence":"additional","affiliation":[{"name":"School of Medicine, The University of Jordan, Amman 11942, Jordan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1880-5125","authenticated-orcid":false,"given":"Runa","family":"Amoudi","sequence":"additional","affiliation":[{"name":"School of Medicine, The University of Jordan, Amman 11942, Jordan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4484-1077","authenticated-orcid":false,"given":"Justin Z.","family":"Amarin","sequence":"additional","affiliation":[{"name":"Office of Scientific Affairs and Research, King Hussein Cancer Center, Amman 11941, Jordan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sura","family":"Al-Ghnimat","sequence":"additional","affiliation":[{"name":"Office of Scientific Affairs and Research, King Hussein Cancer Center, Amman 11941, Jordan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4457-3604","authenticated-orcid":false,"given":"Mamoun","family":"Ahram","sequence":"additional","affiliation":[{"name":"Department of Physiology and Biochemistry, School of Medicine, The University of Jordan, Amman 11942, Jordan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6392-150X","authenticated-orcid":false,"given":"Maysa","family":"Al-Hussaini","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, King Hussein Cancer Center, Amman 11941, Jordan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,2,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s11910-003-0078-x","article-title":"Ependymomas","volume":"3","author":"Chamberlain","year":"2003","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"iv1","DOI":"10.1093\/neuonc\/noy131","article-title":"CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2011\u20132015","volume":"20","author":"Ostrom","year":"2018","journal-title":"Neuro-Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1477-5751-10-7","article-title":"Histopathological grading of pediatric ependymoma: Reproducibility and clinical relevance in European trial cohorts","volume":"10","author":"Ellison","year":"2011","journal-title":"J. Negat. Results Biomed."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00401-016-1643-0","article-title":"The current consensus on the clinical management of intracranial ependymoma and its distinct molecular variants","volume":"133","author":"Pajtler","year":"2017","journal-title":"Acta Neuropathol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1146\/annurev.med.59.053006.104707","article-title":"MicroRNAs in Cancer","volume":"60","author":"Garzon","year":"2009","journal-title":"Annu. Rev. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s10555-019-09820-6","article-title":"Aberrantly expressed microRNAs and their implications in childhood central nervous system tumors","volume":"38","author":"Pezuk","year":"2019","journal-title":"Cancer Metastasis Rev."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s12031-018-1178-z","article-title":"Association of MicroRNAs with the Clinicopathologic Characteristics of Ependymoma","volume":"66","author":"Ahram","year":"2018","journal-title":"J. Mol. Neurosci."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1158\/0008-5472.CAN-07-6754","article-title":"MicroRNAs 221 and 222 bypass quiescence and compromise cell survival","volume":"68","author":"Medina","year":"2008","journal-title":"Cancer Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.canlet.2017.06.031","article-title":"p27Kip1 and human cancers: A reappraisal of a still enigmatic protein","volume":"403","author":"Bencivenga","year":"2017","journal-title":"Cancer Lett."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.devcel.2008.01.013","article-title":"CDK inhibitors: Cell cycle regulators and beyond","volume":"14","author":"Besson","year":"2008","journal-title":"Dev. Cell"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"144351","DOI":"10.1016\/j.gene.2020.144351","article-title":"The clinicopathological and prognostic significance of P27kip in hepatocellular carcinoma patients: A systemic review and meta-analysis","volume":"734","author":"Luo","year":"2020","journal-title":"Gene"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"5651","DOI":"10.1038\/onc.2008.178","article-title":"MiR-221 controls CDKN1C\/p57 and CDKN1B\/p27 expression in human hepatocellular carcinoma","volume":"27","author":"Fornari","year":"2008","journal-title":"Oncogene"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1172\/JCI118631","article-title":"Tumor suppression and inhibition of aneuploid cell accumulation in human brain tumor cells by ectopic overexpression of the cyclin-dependent kinase inhibitor p27KIP1","volume":"97","author":"Chen","year":"1996","journal-title":"J. Clin. Investig."},{"key":"ref_14","first-page":"551","article-title":"Expression of cell cycle regulator p27Kip1 is correlated with survival of patients with astrocytoma","volume":"5","author":"Mizumatsu","year":"1999","journal-title":"Clin. Cancer Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/cncr.11079","article-title":"Low expression of p27 indicates a poor prognosis in patients with high-grade astrocytomas","volume":"97","author":"Kirla","year":"2003","journal-title":"Cancer"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"643","DOI":"10.3325\/cmj.2008.5.643","article-title":"Cyclin D1 and p27 expression as prognostic factor in papillary carcinoma of thyroid: Association with clinicopathological parameters","volume":"49","author":"Punda","year":"2008","journal-title":"Croat. Med. J."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1210\/jcem.87.4.8353","article-title":"Overexpression of cyclin D1 and underexpression of p27 predict lymph node metastases in papillary thyroid carcinoma","volume":"87","author":"Khoo","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1053\/hupa.2001.26462","article-title":"Expression of cell cycle regulators p57(KIP2), cyclin D1, and cyclin E in epithelial ovarian tumors and survival","volume":"32","author":"Rosenberg","year":"2001","journal-title":"Hum. Pathol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.oooo.2018.01.015","article-title":"Expression of cyclin D1 correlates with p27KIP1 and regulates the degree of oral dysplasia and squamous cell carcinoma differentiation","volume":"126","author":"Guan","year":"2018","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1097\/01.MP.0000087420.34166.B6","article-title":"Pediatric intracranial ependymomas: Prognostic relevance of histological, immunohistochemical, and flow cytometric factors","volume":"16","author":"Zamecnik","year":"2003","journal-title":"Mod. Pathol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/neup.12195","article-title":"Immunohistochemical expression of cyclin D1 is higher in supratentorial ependymomas and predicts relapses in gross total resection cases","volume":"35","author":"Marie","year":"2015","journal-title":"Neuropathology"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/j.1750-3639.2012.00600.x","article-title":"Nestin expression identifies ependymoma patients with poor outcome","volume":"22","author":"Milde","year":"2012","journal-title":"Brain Pathol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1097\/00000478-200407000-00011","article-title":"Ki-67 immunolabeling index is an accurate predictor of outcome in patients with intracranial ependymoma","volume":"28","author":"Wolfsberger","year":"2004","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1242\/jcs.025064","article-title":"Cell-cycle-specific nestin expression coordinates with morphological changes in embryonic cortical neural progenitors","volume":"121","author":"Sunabori","year":"2008","journal-title":"J. Cell Sci."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s00412-018-0659-8","article-title":"Ki-67: More than a proliferation marker","volume":"127","author":"Sun","year":"2018","journal-title":"Chromosoma"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.hemonc.2015.02.001","article-title":"Cancer care in Jordan","volume":"8","author":"Attiga","year":"2015","journal-title":"Hematol. Oncol Stem Cell Ther."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1111\/bpa.12866","article-title":"cIMPACT-NOW update 7: Advancing the molecular classification of ependymal tumors","volume":"30","author":"Ellison","year":"2020","journal-title":"Brain Pathol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S0022-510X(00)00347-6","article-title":"Immunohistochemical markers for intracranial ependymoma recurrence. An analysis of 88 cases","volume":"177","author":"Korshunov","year":"2000","journal-title":"J. Neurol. Sci."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1177\/0883073810378750","article-title":"Immunohistochemical expression of cell cycle\/apoptosis regulators and epidermal growth factor receptor in pediatric intracranial ependymomas","volume":"26","author":"Alexiou","year":"2011","journal-title":"J. Child. Neurol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0304-3940(99)00171-8","article-title":"Cell-cycle inhibitor p27\/Kip-1 expression in non-astrocytic and non-oligodendrocytic human nervous system tumors","volume":"264","author":"Schiffer","year":"1999","journal-title":"Neurosci. Lett."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1093\/neuonc\/now016","article-title":"Biology and management of ependymomas","volume":"18","author":"Wu","year":"2016","journal-title":"Neuro-Oncol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1158\/1541-7786.MCR-09-0317","article-title":"p57KIP2: \u201cKip\u201ding the cell under control","volume":"7","author":"Pateras","year":"2009","journal-title":"Mol. Cancer Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/j.jocn.2009.05.007","article-title":"Antigen p57\/Kip2 as a potential negative regulator of human astrocytoma growth","volume":"16","author":"Akaishi","year":"2009","journal-title":"J. Clin. Neurosci."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/nrc3090","article-title":"Cyclin D as a therapeutic target in cancer","volume":"11","author":"Musgrove","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0895-4356(00)00314-0","article-title":"Adjusting for multiple testing--when and how?","volume":"54","author":"Bender","year":"2001","journal-title":"J. Clin. Epidemiol."}],"container-title":["Brain Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-3425\/12\/2\/282\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:21:40Z","timestamp":1760134900000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-3425\/12\/2\/282"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,17]]},"references-count":35,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,2]]}},"alternative-id":["brainsci12020282"],"URL":"https:\/\/doi.org\/10.3390\/brainsci12020282","relation":{},"ISSN":["2076-3425"],"issn-type":[{"type":"electronic","value":"2076-3425"}],"subject":[],"published":{"date-parts":[[2022,2,17]]}}}